Notice on availability of tetanus vaccine in the Republic of Croatia
20.10.2015
Following to the misleading information on shortage of tetanus vaccine on the Croatian market, the Agency for Medicinal Products and Medical Devices would like to inform the public on the availability of this vaccine.
The vaccine Tetavax, suspension for injection in pre-filled syringe, tetanus vaccine, adsorbed is authorised in the Republic of Croatia.
According to the information that HALMED received from the local marketing authorisation holder’s representative for Tetavax, this vaccine is placed on the Croatian market and sufficient amount of the product is available for an undisturbed supply of the Croatian market. From the end of September 2015, 9500 doses of this vaccine has been placed on the Croatian market and in the beginning of November, a delivery of 32000 new doses is expected, therefore, there is no shortage of tetanus vaccine in Croatia.
In the case that there is a discontinuation in the supply chain or shortage of Tetavax, the marketing authorisation holder is obliged to notify HALMED, who will promptly make this information publically available and undertake adequate measures for ensuring adequate supply of the market with this vaccine.
